Open ICICI
3-in-1 Account
Manage your Savings, Demat and Trading Account conveniently at one place
Manage your Savings, Demat and Trading Account conveniently at one place
News: Aurobindo Pharma has received USFDA final approval to manufacture and market Pemetrexed for Injection, 100mg, 500mg and 1000mg (USRLD: Alimta for Injection of Eli Lilly). The approved product is indicated for the treatment of Antineoplastics and has an estimated market size of US$1272 million for the twelve months ending March 2022, according to IQVIA
Views: Pemetrexed is an onco-injectable with big market size and the launch offers a window to ramp up revenues from US, depending on market share gains and offset price erosion in US generics. US contributed 50% to FY21 sales to Aurobindo while company aspires to achieve global sales of US$600-700 million by FY24 from generic injectable
Impact: Positive